CROSS COUNTRY HEALTHCARE INC
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 10, 2026 (15 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jun 8, 2026 | Barrington Research | maintain | Market Perform → Market Perform | — | 56% |
| May 11, 2026 | Truist Securities | maintain | Hold → Hold | — | 54% |
| May 8, 2026 | Benchmark | downgrade | Buy → Hold | — | 54% |
| May 7, 2026 | Wedbush | downgrade | Outperform → Neutral | — | 58% |
| Mar 19, 2026 | Wedbush | upgrade | Neutral → Outperform | — | 58% |
| Mar 5, 2026 | Benchmark | upgrade | Hold → Buy | — | 54% |
| Feb 3, 2026 | Wedbush | initiate | — → Neutral | $11 | 58% |
| Dec 9, 2025 | UBS | maintain | Neutral → Neutral | $9 | 54% |
| Jun 17, 2025 | Barrington Research | maintain | Market Perform → Market Perform | $18.61 | 56% |
| May 13, 2025 | UBS | maintain | Neutral → Neutral | $16.5 | 54% |
| Mar 14, 2025 | Barrington Research | maintain | Market Perform → Market Perform | $18.61 | 56% |
| Feb 6, 2025 | JMP Securities | reiterate | Market Perform → Market Perform | $0 | 53% |
| Dec 10, 2024 | Barrington Research | downgrade | Outperform → Market Perform | $0 | 56% |
| Dec 5, 2024 | Truist Securities | maintain | Hold → Hold | $18.61 | 54% |
| Nov 7, 2024 | Benchmark | maintain | Buy → Buy | $18 | 54% |
| Oct 21, 2024 | Truist Securities | maintain | Hold → Hold | $15 | 54% |
| Aug 8, 2024 | Barrington Research | maintain | Outperform → Outperform | $19 | 56% |
| Aug 1, 2024 | Truist Securities | maintain | Hold → Hold | $17 | 54% |
| May 6, 2024 | Barrington Research | maintain | Outperform → Outperform | $21 | 56% |
| May 2, 2024 | Benchmark | maintain | Buy → Buy | $19 | 54% |
| Feb 27, 2024 | Barrington Research | maintain | Outperform → Outperform | $24 | 56% |
| Feb 22, 2024 | Truist Securities | maintain | Hold → Hold | $16 | 54% |
| Feb 22, 2024 | Benchmark | maintain | Buy → Buy | $21 | 54% |
| Dec 6, 2023 | JMP Securities | initiate | — → Market Perform | $0 | 53% |
| Nov 30, 2023 | UBS | initiate | — → Neutral | $22 | 54% |
| Nov 29, 2023 | Barrington Research | maintain | Outperform → Outperform | $26 | 56% |
| Nov 3, 2023 | Truist Securities | maintain | Hold → Hold | $22 | 54% |
| Nov 3, 2023 | Jefferies | downgrade | Buy → Hold | $21 | 52% |
| Oct 5, 2023 | Jefferies | maintain | Buy → Buy | $32 | 52% |
| Aug 14, 2023 | Barrington Research | maintain | Outperform → Outperform | $29 | 56% |
| Aug 8, 2023 | Credit Suisse | maintain | Neutral → Neutral | $26 | — |
| Jun 26, 2023 | William Blair | initiate | — → Outperform | $0 | 48% |
| Jun 1, 2023 | Barrington Research | maintain | Outperform → Outperform | $35 | 56% |
| May 5, 2023 | Credit Suisse | maintain | — → Neutral | $27 | — |
| May 2, 2023 | Truist Securities | maintain | — → Hold | $25 | 54% |
| Mar 10, 2023 | Loop Capital | initiate | — → Buy | $30 | 54% |
| Feb 23, 2023 | Benchmark | maintain | — → Buy | $40 | 54% |
| Feb 23, 2023 | Credit Suisse | maintain | — → Neutral | $32 | — |
| Nov 7, 2022 | Barrington Research | maintain | — → Outperform | $45 | 56% |
| Oct 5, 2022 | Truist Securities | downgrade | Buy → Hold | $36 | 54% |
| Sep 15, 2022 | Benchmark | maintain | — → Buy | $42 | 54% |
| Jun 13, 2022 | Benchmark | maintain | — → Buy | $37 | 54% |
| Jun 9, 2022 | Credit Suisse | maintain | — → Neutral | $26 | — |
| Feb 24, 2022 | Benchmark | maintain | — → Buy | $42 | 54% |
| Jan 27, 2022 | Jefferies | upgrade | Hold → Buy | $27 | 52% |
| Aug 16, 2021 | Credit Suisse | maintain | — → Neutral | $19 | — |
| Aug 5, 2021 | Benchmark | upgrade | Hold → Buy | $22 | 54% |
| May 6, 2021 | Credit Suisse | maintain | — → Neutral | $13.5 | — |
| May 6, 2021 | Benchmark | downgrade | Buy → Hold | $0 | 54% |
| Feb 25, 2021 | Credit Suisse | maintain | — → Neutral | $11 | — |
No cross-platform signals in the last 90 days